Feedback / Questions
faridoxorubicin (AVA6000) - Avacta
https://www.globenewswire.com/news-release/2026/06/01/3304013/0/en/Avacta-presents-updated-clinical-data-showing-encouraging-early-efficacy-signals-for-AVA6000-in-salivary-gland-cancers-at-ASCO-2026.html
Jun 1, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next